New device aims to starve tumors by cutting off their blood supply

NCT ID NCT06453642

Ongoing Disease control Sponsor: Fluidx Medical Technology, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called GPX that blocks blood flow to tumors or other targeted areas. About 114 adults with conditions like kidney tumors or bone tumors will receive the treatment. The goal is to see if the device is safe and works well at reaching and blocking small blood vessels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

angiomyolipoma bone cancer bone neoplasm kidney angiomyolipoma renal cell carcinoma vascular neoplasm Vascular Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE TUMOR EMBOLIZATION PORTAL VEIN EMBOLIZATION RENAL ANGIOMYOLIPOMA RENAL CELL CARCINOMA VASCULAR TUMOR

Contacts and locations

Locations

Albany Medical Center

Albany, New York, 12208, United States
Atrium Health Carolinas Medical Center

Charlotte, North Carolina, 28203, United States
Auckland City Hospital

Auckland, New Zealand
Christchurch Hospital

Christchurch, 4710, New Zealand
Indiana University Hospital

Indianapolis, Indiana, 46202, United States
MD Anderson Cancer Center - Interventional Radiology

Houston, Texas, 77030, United States
Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
Mount Sinai

New York, New York, 10029, United States
Mount Sinai Hospital Toronto

Toronto, Ontario, M5G 2C4, Canada
Northwestern University

Chicago, Illinois, 60611, United States
St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada
Toronto General Hosptial

Toronto, Ontario, M5G 1Z5, Canada
University of California San Diego Altman Clinical and Translation Research Institute

La Jolla, California, 92037, United States
University of Colorado Anschutz Medical Campus

Aurora, Colorado, 80045, United States
University of Minnesota

Minneapolis, Minnesota, 55455, United States
University of North Carolina

Chapel Hill, North Carolina, 27514, United States
University of Texas Southwestern

Dallas, Texas, 75390, United States
University of Virginia Health System

Charlottesville, Virginia, 22908, United States
Washington University - Barnes Jewish Hospital

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.